healthcare | FinanceAsia

CBC Group buys UCB's China mature neurology and allergy arm

The $680m deal includes UCB's brands Keppra, Vimpat, Neupro, Zyrtec, Xyzal, and its Zhuhai manufacturing site, and was made in partnership with Mubadala Investment Co.

December 03, 2024

Tencent invests $30m into HK-based early cancer detection firm

Insighta, valued at $200m, uses a system designed to detect DNA methylation aberrations in cell-free DNA in bodily fluids such as blood; Prenetics has reduced its stake in the firm.

October 16, 2024

Deals ramp up in Asia’s healthcare space with cancer focus

An acquisition in Hong Kong by the New Frontier Group, an IPO by Sunho Biologics on the HKEX and a $1.5bn investment into Singapore by AstraZeneca, are signs that investments in next generation cancer treatments are increasing in the region.

May 28, 2024

Exploring the investible opportunity in life sciences & healthcare in the Asia Pacific region

Based on bespoke research with investors, professionals active in life sciences and healthcare, and advisors who help in the dealmaking process, as well as an in-depth study of recent trends in the space, the Life Sciences & Healthcare Report 2023 from FinanceAsia in partnership with DFIN offers a succinct and yet comprehensive overview of the investible opportunity in a critical sector.

By DFIN

B Capital strengthens leadership team with three new partners

The additions will allow the venture capital firm to expand its capabilities across sectors and geographies.

February 08, 2022

EQT to double down on healthcare investments, says partner Ken Wong

The firm’s acquisition of Australian healthcare provider, Icon Group, is the latest investment by EQT Infrastructure V. Partner, Ken Wong shares with FA the rationale behind the deal and his plans for further deployment.

November 23, 2021

Prenetics becomes first HK unicorn to go public

Leading diagnostic testing firm Prenetics agrees merger with Artisan, becoming Hong Kong's first unicorn to list on NASDAQ.

September 17, 2021

How BlackRock invests in the future of healthcare

Erin Xie, managing director and portfolio manager at BlackRock, explains the firm’s approach to capturing alpha across the various sub-sectors in this rapidly developing segment of the investment landscape.

March 23, 2021

Innovation drives healthcare private equity in Asia Pacific

A new report by Bain & Company highlights untapped demand and favourable shifts in policies as likely drivers of deal activity in the region’s healthcare sector.

March 16, 2021